Search

everythinglearnresearchcommunity

for

Search:↓

A protein called CBP is found in prostate cancer and can increase the effectiveness of certain prostate cancer treatments.

Prostate cancer prevention includes diet changes, supplements, and medications, with more answers expected soon.

Steroidogenesis inhibitors change but don't stop androgen production in prostate cancer.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

Steroid sex hormones activate matriptase in prostate cancer cells but not in breast cancer cells.

Liarozole may be more effective than cyproterone acetate for treating advanced prostate cancer, with better PSA response and survival rates, while maintaining quality of life.

Certain drugs that block specific enzymes can help treat prostate diseases.

Low androgen levels might delay prostate cancer but could lead to more aggressive, therapy-resistant cancers.

Finasteride might lower the risk of low-grade prostate cancer but not high-grade cancer, while alpha-blockers might reduce high-grade cancer risk.

Ursolic acid can shrink the prostate and lower a hormone linked to prostate growth in rats.

5-α-reductase inhibitors reduce prostate cancer risk but may cause sexual dysfunction and don't affect high-grade tumor or death rates.

Cinnamomi cortex may help treat prostate enlargement by reducing related proteins.

Men who experienced baldness at age 20 may have double the risk of getting prostate cancer.

Finasteride reduces prostate cancer risk but may affect ejaculatory volume and requires careful consideration for young men.

Men with benign prostatic hyperplasia are more likely to have metabolic syndrome than those without it.

The study found no link between baldness patterns and androgen levels in men with benign prostate enlargement or prostate cancer.

Flutamide combined with an LHRH agonist effectively inhibits prostate growth, suggesting it could treat prostate cancer.

Men who start losing hair at age 30 may have a lower risk of prostate cancer.

Early hair loss may indicate prostate issues.

Suppressing certain hormones might help prevent prostate cancer.

Ganoderma lucidum may help treat enlarged prostate in rats.

Dutasteride effectively treats benign prostatic hyperplasia but isn't approved for preventing prostate cancer.

Benign Prostatic Hyperplasia may be caused by changes in how the body processes male hormones.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

Early-onset baldness is linked to a higher risk of aggressive prostate cancer in African-American men, especially before age 60.

Low-dose bisphenol A increases prostate size in rats by affecting certain enzymes.

Corn silk extract helps reduce prostate enlargement symptoms.

5 alpha-reductase inhibitors can slightly improve symptoms of enlarged prostate but have a high risk of sexual side effects.

Family doctors can manage older men with urinary symptoms using exams, tests, and medications.

Hormone therapy for prostate cancer can increase heart risks, especially in men with heart conditions.